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Abstract
 .We have previously reported that induction of nuclear factor-k B NF-k B occurs in a biphasic manner in postischemic
 .  .myocardium. Because interleukin-1 IL-1 , IL-6, tumor necrosis factor-a TNF-a , and inducible nitric-oxide synthase
 .  .iNOS contain k B-response elements, and since transforming growth factor-b1 TGF-b 1 down-modulates both cytokine
 .and iNOS expression, we studied their temporal expression during myocardial ischemiarreperfusion IrR . Northern and
Western analyses showed low levels of IL-6 and no signal for IL-1b , TNF-a and iNOS under basal conditions. Their
expression rose significantly over sham-operated controls by 1 h reperfusion, and persisted high for various periods. Under
basal conditions, low levels of TGF-b1 were detected, which rose significantly at 3 h reperfusion, and remained high until
 .24 h reperfusion. Administration of diethyldithiocarbamate DDC inhibited induction of NF-k B and concomitantly the
expression of IL-1b , IL-6, TNF-a as well as iNOS. However, expression of TGF-b was not altered. Our results indicate
that ischemiarreperfusion induces NF-k B, and upregulates k B-response genes. Administration of DDC inhibits NF-k B
levels, and attenuates expression of inflammatory cytokines and iNOS. q 1998 Elsevier Science B.V.
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1. Introduction
 .Reactive oxygen intermediates ROI are continu-
ously produced as byproducts of electron transfer
Abbreviations: DDC, diethyldithiocarbamate; iNOS, inducible
nitric-oxide synthase; NF, nuclear factor; ROI, reactive oxygen
 .intermediate s ; TNF, tumor necrosis factor; TGF, transforming
growth factor
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reactions in all eukaryotic cells. Oxidative stress,
characterized by unphysiologically high levels of ROI
 .peroxide, superoxide, and hydroxyl radicals may
occur in cells exposed to UV and g irradiation,
stimulation with cytokines, and reperfusion after a
w xperiod of tissue ischemia 1–4 . ROI are also present
in macrophages and neutrophils as important partici-
pants in host defense. Proinflammatory cytokines such
 .as interleukin-1 IL-1 , IL-6 and tumor necrosis fac-
 .tor-a TNF-a are multifunctional molecules, with
overlapping biological activities, which play a causal
role in various inflammatory and infectious diseases.
0925-4439r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
 .PII S0925-4439 97 00062-8
( )B. Chandrasekar et al.rBiochimica et Biophysica Acta 1406 1998 91–10692
They induce their own and each other’s expression
through various second messenger pathways which
involve transcriptional regulators such as activation
 .  .protein AP -1, nuclear factor NF -IL-6, and most
w ximportantly NF-k B 5–9 .
Myocardial reperfusion injury, a condition charac-
terized by contractile dysfunction, usually follows
re-exposure of myocardium to oxygen after a period
w xof sublethal ischemia 1,2 . Recovery of contractile
function depends on the duration of the ischemic
episode with several hours to a day required for
 .complete recovery. Both ROI and nitric oxide NO
are elevated in reperfused postischemic myocardium
w x1,10–14 . Because production of ROI is greatly en-
w xhanced, and ROI activate NF-k B 15 , this factor
may play a key role in postischemic biology of the
heart. In fact, we have shown induction of NF-k B in
a biphasic manner in reperfused myocardium. Be-
cause NF-k B is induced during ischemiarreperfu-
 .sion IrR , it is reasonable to postulate that cytokines
such as IL-1b , IL-6, TNF-a , as well as iNOS which
contain k B-response elements in their promoterren-
w xhancer regions 5–7,16 , will be upregulated during
myocardial reperfusion. In view of the known nega-
tive impact these factors may have on myocardial
function, dissecting the pathways involved in their
regulation during reperfusion is of interest.
 .Transforming growth factor TGF -b 1 is a 25 kDa
homodimeric pleiotropic polypeptide growth factor. It
either stimulates or inhibits immune responses, and
plays a critical role in growth regulation, develop-
ment, inflammation, wound healing and host defense
w x17–19 . It is known to antagonize the activity of
proinflammatory cytokines, and has been shown to
w xinhibit iNOS expression in ˝itro 17–20 . The role of
TGF-b1 in ˝i˝o, especially in the postischemic my-
ocardium, remains to be explored. The purpose of the
present study was to investigate the temporal changes
in mRNA and protein levels of IL-1a , IL-1b , IL-6,
TNF-a , iNOS and TGF-b1 in postischemic my-
ocardium reperfused for various periods of time, and
to determine whether inhibition of NF-k B modulates
expression of these inflammatory molecules. Our re-
sults suggest TGF-b1 may modulate the positive
cascade of ROI-induced cytokine generation in the
heart. Furthermore, inhibition of NF-k B significantly
attenuates the expression of k B-responsive genes in
this model of ischemiarreperfusion.
2. Materials and methods
2.1. Animals and induction of ischemia
WKY rats weighing about 200 g were used for
 .these studies 8 ratsrgroup, total of 88 rats . The
animals were anesthetized with an anesthetic cocktail
44 mgrkg ketamine, 1 mgrkg acepromazine, and
.8.5 mgrkg xylazine , intubated, and placed on a
small animal ventilator. The chest was opened by
midline sternotomy, a 6-0 silk ligature passed around
 .the left anterior descending LAD coronary artery
and passed through a snare. In the ischemiarreperfu-
sion group the snare was tightened until the artery
was occluded. This was readily discernible by the
development of a cyanotic, bulging region of my-
ocardium. Careful note was made of anatomical land-
marks of this region. After 15 min the snare was
released, allowing reperfusion of the ischemic zone.
Animals were randomly assigned to different dura-
tions of reperfusion 15, 30 min, 1, 2, 3, 6, 12 and 24
.h . In sham-operated animals the same procedure was
followed, but the snare was not tightened. After the
experimental period, the heart was rapidly excised
and rinsed in ice-cold physiological saline. The right
ventricle and atria were trimmed away, and the left
ventricle divided into ischemic and non-ischemic
zones and snap frozen in liquid N for further analy-2
ses.
To a separate group of animals ns28; 7 groups
.of 4 each, ;200 g , 15 min before induction of
ischemia, diethyldithiocarbamate diethyldithiocar-
.bamic acid, sodium salt; DDC; Sigma; 150 mgrkg
was administered i.p.. After 15 min of LAD ligation,
the snare was released and the hearts reperfused for
15, 30 min, 1, 2, 3 and 6 h, excised, and processed as
described above.
( )2.2. Electrophoretic mobility shift assay EMSA
The frozen myocardium was broken into small
pieces in the presence of liquid nitrogen, and protein
extracts were prepared by homogenizing Polytron;
.48C; 18 000 rpm the tissue in a buffer containing 20
mM Hepes, pH 7.8, 300 mM NaCl, 0.4 mM EDTA,
0.5 mM DTT, 25% glycerol, and 0.5 mM PMSF,
w xcentrifuged at 14 000 rpm for 10 min at 48C 21 .
Protein concentration was determined by BCA pro-
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 .tein assay reagent Pierce, Rockford, IL . The EMSA
w xwas performed essentially as described 21 with
minor modifications. Briefly, a double stranded
 Xoligonucleotide NF-k B, 5 -AGT TGA GGG GAC
TTT CCC AGG C-3X; Santa Cruz Biotechnology,
.Santa Cruz, CA containing a tandem repeat of the
 Xdecameric consensus sequences 5 -GGGACTTTCC-
X. w 32 x 3 was end-labeled with g- P ATP Amersham,
.Arlington Heights, IL using T4 polynucleotide ki-
 .nase Promega, Madison, WI . The binding reaction
was performed by mixing 20 mg of protein extract, 2
 .  .mg of poly dI-dC Pharmacia, Nutley, NJ and 111
w 32 xTBqrmmol g- P ATP-labeled oligo probe in bind-
ing buffer 20 mM Hepes, pH 7.9, 1 mM MgCl , 4%2
Ficoll, 0.5 mM DTT, KCl to a final concentration of
.50 mM , then incubated for 40 min on ice. For the
 .competition assay the protein extract 20 mg was
preincubated with homologous unlabeled oligo-
nucleotide for 5 min on ice, followed by the addition
of labeled probe. All samples were then elec-
trophoresed at 150 V through 4% polyacrylamide gel
 .0.5=TBE . The gels were dried and autoradio-
graphed with intensifying screens. Absence of protein
extract, competition with 200-fold excess unlabeled
 XNF-k B, and mutant NF-k B oligonucleotide 5 -AGT
TGA GGC GAC TTT CCC AGG C-3X; Santa
.Cruz Biotechnology served as controls.
2.3. Northern blot analysis
Total RNA was extracted by acid-guanidium iso-
w xthiocyanate-phenol-chloroform extraction 22 , and 30
mg of total RNA was size fractionated on 0.8%
agaroser2.2 M formaldehyde gels containing 0.5
mgrml ethidium bromide to check for RNA integrity
and loading equivalency, electrotransferred onto
nitrocellulose membrane and fixed by UV irradiation
 . w xStratalinker 2400, Stratagene, La Jolla, CA 23 .
The blots were prehybridized for 1 h at 428C in a
prehybridization buffer that contained 50% for-
mamide, 0.1% SDS, 5=SSC, 2.5=Denhardt’s, 250
mgrml salmon sperm DNA, 50 mM Na PO , pH2 4
6.5. The blots were then hybridized at 428C for 16 h
with the labeled cDNAroligonucleotide probe 6=
5 .10 cpmrml , washed twice at 238C in 6 =
SSCr0.5% SDS, twice at 378C in 1=SSCr0.5%
SDS, and once at 578C in 0.l=SSCr0.5% SDS. All
blots were exposed at y808C to Kodak XAR-5 film
with Kodak intensifying screens. mRNA sizes were
determined in relation to the relative mobility of 28S
and 18S rRNA, and an mRNA ladder GibcoBRL,
.Grand Island, NY . cDNA probes were labeled with
w 32 x  .a- P dCTP 3000 Cirmmol; Amersham to a spe-
 .cific activity of 0.5–1 =109 cpmrmg, using ran-
dom hexanucleotide primers Boehringer Mannheim,
. XIndianapolis, IN , and oligonucleotide probes were 5
w 32 xend-labeled with g- P ATP using T4 polynu-
cleotide kinase.
The following cDNA and oligo probes were used:
 . mIL-1a 2.0 kb, BamHI-HindIII , mIL-1b 0.6 kb,
.  . BamHI-SmaI , mIL-6 1.0 kb, EcoRI , hTNF-a 1.3
. kb, BamHI-HindIII , and rTGF-b1 0.99 kb; Ameri-
.can Type Culture Collection, Rockville, MD , mouse
iNOS 1.8 kb; Cayman Chemical Co., Ann Arbor,
. MI and h28S rRNA 40 base single stranded oligo;
.Oncogene Science, Uniondale, NY .
2.4. Western blot analysis
 .Equal amounts of homogenates 60 mg from con-
trol and experimental heart tissue were subjected to
 . either 10% iNOS or 16.5% IL-1b , IL-6, TNF-a ,
.TGF-b1 SDS-PAGE, and electroblotted onto nitro-
 . w xcellulose membranes S&S, Keene, NH 23,24 . The
membranes were incubated with 10% normal goat
 .serum pre-immune to block for non-specificity fol-
lowed by incubation at 238C for 1 h and 48C for 18 h
with the relevant primary antibody. Optimal concen-
trations of antibodies were determined in separate
experiment. The membranes were washed with a
 .buffer containing 20 mM Tris pH 7.5 , 500 mM
 .NaCl, and 0.05% vrv Tween-20, and then incu-
bated sequentially with goat-anti-rabbit IgG
 .Kirkegaard and Perry Labs, Gaithersburg, MD for 2
125 h at 238C, and I-protein A 0.33 mCirml; Amer-
.sham for 2 h at 238C. Autoradiography and
densitometry of autoradiograms were carried out as
described below.
Anti-mouse antibodies which cross-reacted with
rat IL-1b , IL-6 and TNF-a were obtained commer-
 . w xcially from R&D Systems Minneapolis, MN 24 ,
and were used at a concentration of 3.5 mgrml
 .  .IL-1b , TNF-a and 5 mgrml IL-6 . Polyclonal
antibodies against iNOS non cross-reactive with
constitutive form of neuronal or endothelial NOS;
. used at 3.5 mgrml and TGF-b1 non cross-reactive
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.with TGF-b 2 or TGF-b 3; used at 5 mgrml were
obtained from Santa Cruz Biotechnology. Specificity
of antibodies was verified by incubating the antibod-
ies with their respective antigens for 1 h at 378C
followed by 14 h at 48C.
2.5. Densitometric analysis
To quantify the intensity of autoradiographic sig-
nals obtained by Northern blot, Western blot and
Fig. 1. Control studies determining the specificity of NF-k B
oligonucleotide probe by EMSA. Lane 1: No protein but contains
w 32 xg- P ATP-labeled k B-specific probe. Lane 2: Protein extract
from 1 h reperfused myocardium was preincubated with 200-fold
molar excess of unlabeled double stranded oligonucleotide en-
compassing the NF-k B binding motif followed by the addition of
k B specific probe. Lane 3: Competition with mutant NF-k B
oligonucleotide. Protein extract from 1 h reperfused myocardium
was preincubated with 200-fold molar excess of unlabeled double
stranded mutant NF-k B oligo followed by the addition of k B
specific probe. Lanes 4–15: Protein extract from normal tissue
adjacent to ischemic myocardium 15, 30 min, 3, and 6 h
.reperfusion qk B specific probe. Lanes 16–20: Protein extract
 .from control sham-operated myocardiumqk B-specific probe.
Solid arrow: NF-k B specific binding region. Open arrow: non-
specific band. Solid circle: free probe.
EMSA, we employed a desktop digital imaging
w xmethod with an optical scanner 25 . Briefly, the
autoradiograms were scanned by standard video
imaging equipment connected to a Power Macintosh
computer and the image was analyzed using an NIH
1.59 image analysis software package with an inte-
grated density program. The area analyzed for each
band was kept constant for all the bands in an
autoradiogram. Background density on the autoradio-
gram was subtracted from the densitometric data of
each band. For Northern blotting, the results were
expressed as a ratio of specific gene to that of
corresponding 28S expression to ensure equal loading
of RNA. In Western blotting and EMSA, compar-
isons were made with values obtained from sham-op-
 .erated control animals.
2.6. Assessment of myocardial necrosis
In order to assess necrosis in reperfused my-
ocardium, we followed a technique described previ-
ously by Nolan et al. using anti-myosin antibodies
mouse mAb; CCM-52 subclone 6; a kind gift from
Dr. W. A. Clark, Michael Reese Hospital and Medi-
. w xcal Center, Chicago, IL 26 . This antibody is raised
against 12 day-old chick cardiac myosin and specifi-
cally detects cardiac myosin. Necrotic myocytes ex-
hibit sarcolemmal permeability thus allowing these
antibodies to enter the cells. Rather than entering the
cells passively, these antibodies are concentrated by
binding to myofibrillar myosin. Intact, uninjured cells
w xexclude the antibody and remain unlabeled 27 . When
administered, the antibodies appear in serum within 1
h and reach maximal enzyme-linked immunosorbent
assay serum titers by 3 h, and remain high for more
than a week after a single i.p. administration. Eight
hours after administration of these antibodies 100
wmg in 0.2 ml phosphate-buffered saline 50 mM
x .phosphate, 200 mM NaCl, pH 7.4 ; i.p.; ns4 , the
animals underwent 15 min of ischemia and 1 h
reperfusion. The animals were killed, hearts sepa-
rated, washed in ice-cold saline, the right ventricle
and atria trimmed away. The left ventricle was di-
vided into ischemic and non-ischemic zones and em-
bedded in OCT, snap frozen in liquid N and stored2
for not more than three days at y828C. Six microme-
ter-thick cryosections were made, air dried at 228C
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for 30 min, fixed for 10 min in ice-cold acetone, air
dried for 15 min. The sections were rehydrated in
 .PBS 3 min, 5= , and incubated for 30 min at 378C
in a humidified chamber in the dark with TRITC
 .tetramethylrhodamine isothiocyanate -conjugated
 .rabbit anti-mouse IgG 1:40 dilution, Sigma in PBS
w xcontaining 1% BSA fraction V 28 . The sections
 .were then washed in PBS 3 min, 5= , and mounted
with coverslips in fluorescent mounting medium
 .DAKO . The slides were stored in the dark at 48C
before microscopic analysis.
As a positive control we used animals treated with
the b-adrenergic agonist isoproterenol, which has
previously been shown to induce extensive necrosis
w x27 . One hour prior to isoproterenol administration,
 .normal uninfected rats ns4 were injected i.p. with
CCM-52 mAb. Isoproterenol hemisulfate Sigma; 1
.mgrkg dissolved in PBS , was injected subcuta-
neously. After 8 h, animals were sacrificed, and
hearts processed as described above. As a negative
control, we used healthy, PBS-injected rats with
CCM-52 mAb.
2.7. Statistical analysis
Data shown are means"1 S.E.M. Data were sub-
jected to analysis of variance with Student’s t-test for
significance. Correction for multiple comparisons
were made using the Bonferroni factor. P values of
0.05 or less were considered significant.
Fig. 2. Electrophoretic mobility shift analysis for NF-k B levels in reperfused myocardium. Lane 1: No protein but contains
w 32 xg- P ATP-labeled k B-specific probe. Lane 2: Protein extract from 15 min reperfused myocardium was preincubated with 200-fold
molar excess of unlabeled double stranded oligonucleotide encompassing the NF-k B binding motif followed by the addition of k B
specific probe. Lane 3: Competition with mutant NF-k B oligonucleotide. Protein extract from 15 min reperfused myocardium was
preincubated with 200-fold molar excess of unlabeled double stranded mutant NF-k B oligo followed by the addition of k B specific
probe. Lanes 4–19: Protein extract from myocardium reperfused for the indicated periodsqk B specific probe. Lanes 20: No
proteinqk B specific probe. Lane 21: Competition with mutant NF-k B: protein extract from 3 h reperfused myocardium was
preincubated with 200-fold molar excess of unlabeled double stranded mutant NF-k B oligo followed by the addition of k B specific
probe. Lane 22: Competition with unlabeled NF-k B. Lane 23–38: Protein extract from myocardium reperfused for the indicated
periodsqk B-specific probe. Solid arrow: NF-k B specific binding region. Open arrow: non-specific band. Solid circle: free probe.
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3. Results
3.1. Le˝els of NF-kB DNA binding acti˝ity
NF-k B levels were detectable at low levels in
myocardium from both sham-operated control
 .densitometry; 55.8"1.42 and from normal my-
ocardium adjacent to the ischemic zone internal
.  .control in experimental animals Fig. 1 . In postis-
chemic myocardium, NF-k B levels as a measure of
intensity of autoradiographic bands obtained in
.  .EMSA were higher at both 15 min reperfusion R
 .163.5"41.9, 2.9-fold; P-0.025 and 30 min R
 .228.5"7.5, 4.1-fold, P-0.0001 declining there-
 . after Fig. 2 . The levels rose again at 3 h R 303.5"
.54.2, 5.4-fold; P-0.005 and remained high at 6 h
 .R 175"19.5, 3.1-fold; P-0.0001 , falling to basal
 .levels by 12 h R 52"1.63; Fig. 2 . These results
w xconfirm our earlier observations 23 which indicate
biphasic time-dependent changes in NF-k B levels in
reperfused myocardium.
Because no change in the NF-k B was observed in
both sham-operated and in non-ischemic regions of
the myocardium from experimental animals, subse-
quent studies utilized myocardium from sham-oper-
ated animals as control.
3.2. IL-1b , IL-6 and TNF-a expression
Fig. 3 shows the autoradiograms of Northern blots
for the three proinflammatory cytokines. When com-
Fig. 3. Proinflammatory cytokine mRNA expression in control and postischemic myocardium. Each lane represents total RNA from an
individual animal. Thirty micrograms of total RNA per lane was electrophoresed, electroblotted onto nitrocellulose, and fixed by UV
irradiation. The blot was reprobed after stripping off previous probe. mRNA sizes were determined in comparison to the relative mobility
 .of 28S and 18S and to that of the mRNA ladder 0.2–9.5 kb; GibcoBRL . 28S rRNA was used as an internal control and indicates equal
levels of RNA loading in all lanes of the gel. The autoradiographic time was 3 days for all the cytokines, and 12 h for 28S rRNA. Even
after 8 days of exposure, no signal was detected in lanes that did not have detectable levels of mRNA.
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pared to sham-operated control densitometric analy-
sis, mean"S.E.M., ratio of specific gene expression
.to that of 28S rRNA , myocardium from the postis-
chemic zones expressed no signals for either IL-1b
or TNF-a , and a weak signal for IL-6 0.175"
.0.005 . After 1 h R, signals for all three cytokines
increased by at least 4.8-fold over control IL-1b ,
0.711"0.022; IL-6, 0.816"0.029; TNF-a , 0.701"
.0.096; all P-0.01 . After 3 h R, expression of
 .  .IL-1b 0.72"0.072 and TNF-a 0.49"0.091 had
dropped to levels between control and that present at
1 h, while the signal for IL-6 remained at the same
 .level 0.80"0.09 and continued to be elevated until
 .6 h 0.6"0.13, 3.5-fold; P-0.01 , and fell to basal
 .levels by 12 h R 0.158"004; Fig. 3 . The observed
changes in gene expression could not be attributed to
nonspecific effects of ischemiarreperfusion on over-
all myocardial gene expression as observed for 28S
ribosomal RNA message which was the same in both
control and experimental animals. In addition, we
were not able to detect a signal for IL-1a mRNA in
either control animals or from post ischemic tissue
even after prolonged autoradiographic exposure 8
.days . This behavior, of other control genes, con-
firmed that our results were highly specific and re-
sulted from the ischemic insult.
The results from immunoblotting for the proin-
flammatory cytokines are shown in Fig. 4. While low
levels of IL-6 protein were detected in the sham-op-
 .erated controls densitometry; 70.5"1.5 , no protein
was detected for IL-1b or TNF-a. However at 1 h R
IL-1b , 135"12.28; IL-6, 224.5"24.92, 3.2-fold;
. TNF-a , 164"2.16 , 2 h R IL-1b , 136"12.3; IL-6,
.286"6.97, 3.2-fold; TNF-a , 163"3.51 and 3 h R
IL-1b , 127"20.3; IL-6, 268.5"4.64, 3.2-fold;
.TNF-a , 184"7.16 the cytokines were readily de-
tected. The pattern of protein expression, however,
differed somewhat from that for the mRNA. While
the mRNA for TNF-a was highest at 1 h R, the
protein levels were highest at 3 h R with subsequent
 .return toward baseline Fig. 4 . For IL-1b , protein
was detected at 1 h R, and remained elevated 3 h
 .3.8-fold; P-0.0001 , and returned to baseline val-
ues by 12 h R. For IL-6, protein was elevated at 1 h
 .3.1-fold; P-0.0001 , and further elevated at 3 h R.
Further, in addition to a specific 26 kDa protein
Fig. 4. Western blot analysis of protein homogenates isolated from control and postischemic myocardium. Equal amounts of protein per
lane were electrophoresed using 16.5% SDS-PAGE. The separated proteins were electroblotted onto nitrocellulose. After blocking with
10% normal goat serum, the membrane was sequentially incubated with the primary, secondary and 125I-Protein A. Autoradiographic
exposure time was 4 days for all the three cytokines. Pre-stained molecular weight standards were shown on the left. Arrow indicates the
relative position of protein detected by the respective antibody. No signal was detected even after 8 days of autoradiographic exposure in
lanes that did not have detectable levels of signal.
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Fig. 5. Inducible NOS and TGF-b1 mRNA expression in postischemic myocardium. Each lane represents total RNA from an individual
animal. Thirty micrograms of total RNA per lane was electrophoresed, electroblotted onto nitrocellulose, and fixed by UV irradiation. The
blot was reprobed after stripping off previous probe. The autoradiographic time was 3 days for iNOS and TGF-b1, and 12 h for 28S
rRNA. Even after 8 days of exposure, no signal was detected in lanes that did not have detectable levels of mRNA.
Fig. 6. Western blot analysis of protein homogenates extracted from control and postischemic myocardium. The Autoradiographic
exposure time was 4 days for both iNOS and TGF-b1. Pre-stained molecular weight standards were shown on the left. The arrow
indicates the relative position of protein detected by the respective antibody. No signal was detected even after 8 days of autoradiographic
exposure in lanes that did not have detectable levels of signal.
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Fig. 7. Effects of diethyldithiocarbamate on NF-k B levels. 15 min after DDC administration, a 15 min ischemia was induced followed by
various periods of reperfusion. EMSA for NF-k B levels was performed essentially as described in Section 2.2. Competition experiments
 .  .using unlabeled mutant competed-mutant NF-k B and consensus competed-NF-k B oligo were performed to determine the specificity
of the probe. Numbers 1–4 indicate myocardium from four different animals after the indicated periods of reperfusion. Solid arrow:
NF-k B specific binding region. Open arrow: non-specific band.
Fig. 8. Effects of diethyldithiocarbamate on proinflammatory cytokine mRNA expression in postischemic myocardium. Each lane
represents thirty micrograms of total RNA from an individual animal. The autoradiographic time was 3 days for all the cytokines, and 12
h for 28S rRNA.
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Fig. 9. Effects of diethyldithiocarbamate on proinflammatory cytokine protein levels in postischemic myocardium as assessed by Western
blot analysis of protein homogenates isolated from control and postischemic myocardium. Equal amounts of protein per lane were
electrophoresed using 16.5% SDS-PAGE. Pre-stained molecular weight standards were shown on the left. Arrow indicates the relative
position of protein detected by the respective antibody.
Fig. 10. Effects of diethyldithiocarbamate on iNOS and TGF-b1 mRNA expression in postischemic myocardium. Each lane represents
thirty micrograms of total RNA from an individual animal. The autoradiographic time was 3 days for iNOS and TGF-b1, and 12 h for
28S rRNA.
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detected by anti-IL-6 antibodies, several other bands
 .‘ladder-like’ were also detected,which may indicate
either non-specific bands or the glycosylated forms of
IL-6.
3.3. iNOS and TGF-b1 expression
Because IL-1b , IL-6 and TNF-a are potent induc-
 .ers of nitric-oxide synthase iNOS , and TGF-b1 is
known to down-modulate both proinflammatory cy-
tokine and iNOS expression, we also assessed my-
ocardial mRNA and protein levels for iNOS and
 . TGF-b1 Figs. 5 and 6 . The results densitometry;
mean"S.E.M.; ratio of specific gene to that of its
.28S indicate that iNOS mRNA was not detected in
control tissue, and was not found in ischemic tissue
 .until 1 h R 0.34"0.06; Fig. 5 . The levels increased
 .at 2 h R 1.12"0.01 , and remained high until 6 h R
 .1.02"0.20 , after which the levels fell to 0.16"
0.01 by 24 h R. On the other hand, TGF-b1 mRNA
 .expression was minimal in controls 0.25"0.02 and
remained at this baseline level until 2 h R 0.24"
. 0.03 , rose significantly higher at 3 h R 2.1-fold;
. P-0.0001 , increased further by 6 h R 4.1-fold;
. P-0.0001 , and remained high until 24 h R 3.6-fold;
.P-0.0001; Fig. 5 . Western blot analysis showed
iNOS levels to be at their highest level at 2 h R
 .134.5"4.85; 6.04-fold; P-0.0001 falling there-
after to minimal levels 3 h R, 81"0.57; 6 h R,
.80.5"0.5; Fig. 6 . TGF-b1 protein levels rose by 3
 .h R 168"5.9; P-0.05 and progressively in-
creased, with highest levels at 12 h R 287"2.88;
.3.12-fold; P-0.01; Fig. 6 .
3.4. Effects of diethyldithiocarbamate
Because induction of NF-k B and overexpression
of k B-responsive genes was observed during reper-
fusion, we investigated the effects of DDC, a free
radical scavenger as well as an NF-k B inhibitor
w x29–33 , on NF-k B, cytokine, and iNOS expression
in reperfused myocardium. Since the majority of
changes in gene expression and protein level oc-
curred before 6 h R, we chose to study the effects of
DDC up to 6 h R. While biphasic regulation was seen
 .in saline injected rats Fig. 2 , DDC significantly
 .inhibited NF-k B at 15, 30 min, and 3 h R Fig. 7 .
Fig. 11. Analysis for necrosis in postischemic reperfused my-
ocardium. After 15 min of LAD coronary artery occlusion, the
hearts were reperfused for 1 h, and processed essentially as
 .described in Section 2.6. A Negative control: Myocardium from
a healthy normal rat administered with CCM-52 anti-myosin
 .mAb showing no necrosis. B Myocardium from a 1 h reper-
fused animal preadministred with CCM-52 mAb. In four different
animals, out of 32 sections, only one cell was seen stained
positive in the postischemic zone, indicative of rare occurrence of
cardiomyocyte necrosis during reperfusion following a brief sub-
 .lethal ischemia. C Positive control: Myocardium from an ani-
mal administred with isoproterenol, a b-adrenergic agonist, that
induces extensive necrosis in the heart. Several positively stained
cells were seen, indicative of substantial necrosis. A representa-
tive photomicrograph is shown from each group. Arrows indicate
cells stained positive for necrosis. Magnification: =400. Repro-
.duced at 92%.
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mRNA analysis showed low levels of IL-1b at 1 h
R; its level increased by 2 h R, but was significantly
 .lower compared to saline injected rats Fig. 8 . At 3 h
R only 2 of 4 animals expressed even low levels of
IL-1b. While absolute levels were decreased, no
significant change in the pattern of IL-6 expression
 .was observed in DDC administered animals Fig. 8 .
While no signals were detected for TNF-a until 1 h
R; its level increased at 2 h R, but fell thereafter,
indicating a significant inhibition in its expression by
 .DDC Fig. 8 . Western blot analysis showed a sub-
stantially lower protein levels for all three cytokines
 .Fig. 9 . A weak signal for IL-6 and no signal for
IL-1b and TNF-a was detected at 1 h R; their levels
increased at 2 h R, but were significantly lower than
 .saline treated rats Fig. 9 . Fig. 10 shows mRNA
levels of iNOS and TGF-b1. DDC significantly in-
hibited iNOS at 2 h R, and very low levels were
detected at 3 h R. While all the proinflammatory
molecules are significantly inhibited by DDC, expres-
 .sion of TGF-b1 was not altered Fig. 10 . These
results indicate that by inhibiting NF-k B levels, DDC
down-modulated proinflammatory cytokine as well as
iNOS expression in postischemic reperfused my-
ocardium, but did not affect TGF-b1.
3.5. Histological analysis for necrosis
Because oxidative stress plays a major role in
reperfusion injury, we analyzed postischemic reper-
fused myocardium for the extent of necrosis. One
hour reperfusion was chosen since all three proin-
flammatory cytokines are induced at this time. To
detect necrotic cells, we injected anti-myosin antibod-
 .ies CCM-52 intraperitoneally 8 h prior to induction
of ischemia. Cells undergoing necrosis will have
compromised sarcolemma, and are permeable to these
antibodies. Once they enter the cell, they specifically
bind to myosin, and the bound antibodies can be
detected by immunofluorescence. The upper panel in
Fig. 11 shows myocardium from a healthy, normal
rat injected with CCM-52 mAb, and demonstrating
the absence of myocardial necrosis. Among four
 . animals 1 h R tested 8 sections from each rat, total
.of 32 , only one cell positive for necrosis was de-
 .tected middle panel . The lower panel shows my-
ocardium from a rat administered isoproterenol posi-
.tive control showing several cells exhibiting necro-
sis. These results indicate that necrosis is a very rare
occurrence in reperfused myocardium after a single
15 min episode of sublethal ischemia.
4. Discussion
Our results show increase in NF-k B levels in a
biphasic manner in myocardium during reperfusion
following a 15 min period of ischemia. In addition,
increased IL-1b , IL-6, TNF-a and iNOS expression
was observed for several hours following reperfusion,
and protein levels for these proinflammatory cy-
tokines paralleled their individual levels of mRNA
expression. Interestingly, upregulation in TGF-b1
expression was observed at a later period and its
expression remained high until 24 h of reperfusion.
Reperfusion after a brief period of ischemia is
associated with excessive production of free radicals
 .ROI and NO by both resident cardiomyocytes and
w xactivated polymorphonuclear cells 1–4 . ROI have
previously been shown to activate NF-k B in a num-
w xber of experimental systems 15 . NF-k B is a multi-
subunit transcription factor which is constitutively
located in the cytoplasm in an inactive state bound to
w xan inhibitory molecule, Ik B 5 . Following an appro-
priate stimulus, NF-k B dissociates from Ik B,
translocates to the nucleus, and binds to
promoterrenhancer regions of genes containing k B
response elements. Confirming our previous results
w x23 , we observed a biphasic regulation in NF-k B
levels in the postischemic myocardium with elevation
of levels at 15 min and 3 h reperfusion in the present
study. Work by Bolli and colleagues, using spin-trap
NMR techniques, has shown that in canine hearts
subjected to coronary ligation, ROI peaks 2–3 min
w xfollowing the initiation of reperfusion 34 . Our data
suggest that this initial burst of ROI may have con-
tributed to an initial rise in NF-k B, which was
elevated after only 15 min of reperfusion. Further-
more, proinflammatory cytokines, including IL-1b ,
IL-6 and TNF-a contain k B response elements such
wthat they can be induced by activated NF-k B 5–
x7,16,35 . These cytokines, in addition to enhancing
ROI production, activate NF-k B through various sec-
w xond messenger systems 5 . This suggests that the
second surge in NF-k B levels, which we observed at
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3 h reperfusion, may result from the stimulation
provided by these cytokines. While this thesis is
plausible, it remains unproven, and further studies
will be required to elucidate the precise mechanisms
involved in the biphasic upregulation of NF-k B in
the postischemic myocardium.
Interleukin-1, IL-6 and TNF-a have overlapping
biological activities, and can regulate their own and
each other’s expression by both autocrine and
w xparacrine mechanisms 7,36,37 . Their effects vary
depending on the cell type involved and the disease
state. A large number of studies have shown that
TNF-a depresses cardiac contractile performance,
and this cytokine is felt to participate in the myocar-
w xdial depression present in endotoxic shock 38–41 .
While less work has been done on cardiac effects of
other proinflammatory cytokines, IL-6 has been
shown to impair papillary muscle contractile function
w xin ˝itro 42 . These observations suggest that rapid
production of inflammatory cytokines during reperfu-
sion may contribute to reduced function and possibly
to tissue damage in reperfusion injury. In the present
study we found that after a 1 h period of reperfusion
there was induction and expression of all the three
cytokines, and that this increased expression lasted
for at least 3 h in the case of IL-1b and TNF-a , and
until 6 h reperfusion for IL-6. In a previous study,
Herskowitz and colleagues also showed increased
levels of mRNA for these cytokines in myocardium
from rats following coronary ligation and reperfusion
w x43 . Using RT-PCR they showed induction of all the
three cytokines after 15 min of reperfusion, with
levels returning to baseline values by 3 h of reperfu-
sion. Their study was done in hearts reperfused after
a 35 min ischemic insult, a long enough time to elicit
w xtissue necrosis 44 , leaving in doubt how to compare
the results to our study, in which necrosis was not
present. Further work will be needed to assess whether
differences in cytokine response are present follow-
ing lethal and sublethal periods of ischemia.
Unlike IL-1b and TNF-a , which are known to
depress myocardial contractile function, the role of
IL-6 is still debated. IL-6 acts both as anti-inflamma-
tory and in some respects as a proinflammatory
molecule depending on the nature of the target cell. It
has been shown to play a pathological role in dis-
eases such as cardiac myxoma, autoimmune lupus
w xnephritis, arteriosclerosis, and in endotoxemia 7,45 .
On the other hand, its role in defense mechanisms
regulating immune and acute phase reactions has also
been demonstrated. Reports from in ˝i˝o studies, in
which mice were injected with LPS and in ˝itro
studies in which macrophage cultures were exposed
to LPS, both IL-1 and TNF-a expression was inhib-
w xited by pretreatment with IL-6 46,47 . In addition, by
enhancing soluble receptors of IL-1 and TNF-a , IL-6
w xneutralized circulating IL-1 and TNF-a 48 , demon-
strating its anti-inflammatory properties. To date,
however, it is not known whether this cytokine plays
a protective or causal role in reperfusion injury.
Another important participant in the inflammatory
w xprocess is NO 49 , which our data suggests is present
in the postischemic myocardium. The 5X-flanking re-
gion of the iNOS gene is quite complex and contains
consensus sequences for several transcription factors,
w xsome in multiple copies 16 . These include two
copies of the NF-k B response element, and two
copies of a TNF-response element. Supporting evi-
dence for the efficacy of these inducers has been
shown in several tissues other than the myocardium.
In studies on macrophages, Goldring et al. have
demonstrated that reducing NF-k BrRel activity leads
to a reduction in both iNOS protein level and iNOS-
w xmediated NO output 50 . Geller and colleagues have
shown that in hepatocytes, TNF-a and IL-1 in com-
bination provide a highly effective double signal
w xcombination in the induction of iNOS mRNA 51 .
Moreover, strong induction of NOS mRNA and
marked increase in NOS activity were also seen when
w xTNF-a or IL-1 was the sole stimulus 51 . Thus, in
view of the presence of NF-k B and proinflammatory
cytokines in the postischemic myocardium, condi-
tions for the transcription of iNOS are clearly present.
Our results demonstrate increased levels of iNOS
mRNA as well as iNOS protein, confirming that this
inflammatory mediator is present, beginning at 1 h,
and persisting for 3 h after a brief period of ischemia.
Given the fact that ischemia releases ROI, which
induces NF-k B, which in turn induces proinflamma-
tory cytokines capable of further inducing NF-k B,
conditions for a positive feedback amplification loop
would appear to be present. It is notable from our
data, however, that the second rise in NF-k B is not
followed by a subsequent elevation in mRNA for
proinflammatory cytokines or iNOS. Prior work has
shown that TGF-b can down-modulate the expres-
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w xsion of cytokines 17–20 . Using isolated cardiac
myocytes, Pinsky et al. have shown a significant
inhibition in cytokine-inducible NOS expression by
w xTGF-b 20 . Similar observations were reported in
macropahges and in vascular smooth muscle cells
w x52,53 , and it has been hypothesized that TGF-b
exerts its inhibitory effects on these inflammatory
mediators by mechanisms such as decreasing mRNA
stability, decreasing translation, or increasing protein
w xdegradation 54 . In the present study, low levels of
TGF-b1 mRNA levels were detected under basal
conditions, but rose significantly at 3 h of reperfu-
sion, and continued to remain high until 24 h of
reperfusion. By contrast, mRNA for cytokines and
iNOS reached basal levels at 3 h reperfusion, indicat-
ing that increased TGF-b might have suppressed
their expression during reperfusion. Lefer and col-
leagues have shown that preadministration of TGF-b
to rats subjected to myocardial infarction was associ-
ated with a smaller loss of creatine kinase evidence
. w xof a smaller infarct 55 . While in our study signifi-
cantly higher levels of NF-k B were present at 3 and
6 h reperfusion, the levels of the proinflammatory
cytokines potentially induced by it fell back to basal
levels after 3 h reperfusion with the exception of
IL-6 which had levels that were still high at 6 h
.reperfusion, falling thereafter . This raises the inter-
esting possibility that down-modulating properties of
TGF-b may have blocked the secondary induction of
these cytokines by NF-k B, thereby interfering with
inflammatory amplification within the myocardium.
Though the mechanism of maintaining increased
TGF-b levels until 24 h of reperfusion is not known,
it is possible that once induced, TGF-b can maintain
its levels for a long period through autoinduction
w x17 , and therefore may protect the myocardium from
the deleterious effects of inflammatory mediators.
Because NF-k B is induced, and k B-response
genes are upregulated during reperfusion, we at-
tempted to inhibit the induction of NF-k B pharmaco-
logically. By administering DDC 15 min before coro-
nary ligation both phases of NF-k B and expression
of IL-1b , IL-6, TNF-a as well as iNOS were signifi-
cantly attenuated, while expression of TGF-b was
not altered. Though DDC was exploited earlier for
 w x.the treatment of metal poisoning reviewed in 33 ,
reports of its use as a free radical scavenger and as an
NF-k B inhibitor are now emerging. Using brain tis-
sue, Liu et al. have demonstrated the powerful antiox-
w xidant properties of DDC 32 . They found that DDC
scavenged hypochlorous acid, hydroxyl radicals, and
peroxinitrite, and blocked generation of hydroxyl rad-
icals. Inhibition of oxidative damage to DNA and
w xprotein were also observed 32 . In cultured vascular
smooth muscle cells, DDC was found to enhance
vascular reactivity by inhibiting either LPS or LPSq
w xTNF-a-mediated NOS expression 56 . Using murine
bone marrow-derived macrophages, Mulsch et al.
have shown significant inhibition of NOS mRNA
expression, its enzyme activity and NO generation,
and attributed these beneficial effects of DDC to
w xinhibition of NF-k B 57 . Further, Schreck and col-
leagues have shown that the pyrrolidone derivative of
 .dithiocarbamate PDTC inhibits cytokine-, LPS-, and
oxidative stress-induced activation of NF-k B in vari-
w xous cell systems 30 . They suggest that dithiocarba-
mates may suppress a reaction required for release of
Ik B from NF-k B in the cytoplasm. Because PDTC
could block this reaction in response to every NF-k B
inducer tested, it is probable that dithiocarbamates
interfere with the activity of a common messenger,
possibly ROIs, produced by different signaling path-
ways. Since PDTC is only effective under in ˝itro
conditions, we used DDC. It is likely that by similar
 .mechanism s , DDC might have inhibited NF-k B,
and the k B-responsive genes in the postischemic
reperfused myocardium.
In conclusion, our results are consistent with the
hypothesis that NF-k B, which is involved in the
regulation of a variety of genes, is a key transcrip-
tional modulator of both proinflammatory cytokines
and iNOS in the postischemic myocardium. In addi-
tion, intrinsic regulation of the postischemic inflam-
matory response may involve TGF-b. Further, inhibi-
tion of NF-k B by DDC attenuates proinflammatory
cytokine and iNOS expression, suggesting that NF-
k B regulation plays an important role in postis-
chemic myocardial pathobiology.
Acknowledgements
This research was supported by the Research Ser-
vice of the Department of Veterans Affairs. The
authors wish to thank Dr. W.A. Clark, Cardiovascular
Institute, Michael Reese Hospital and Medical Cen-
( )B. Chandrasekar et al.rBiochimica et Biophysica Acta 1046 1998 91–106 105
ter, Chicago, IL for the kind gift of anti-myosin mAb,
Danny Escobedo and Cindy Ramirez for excellent
technical assistance, and Dr. Michael Fischbach for
helpful criticism of the manuscript.
References
w x  .1 R. Bolli, Circulation 6 1992 1671–1691.
w x2 J.R. Woodgett, J. Avruch, J.M. Kyriakis, Clin. Exp. Phar-
 .macol. Physiol. 22 1995 281–283.
w x3 R. Schreck, K. Albermann, P.A. Baeuerle, Free Radic. Res.
 .Commun. 17 1992 221–237.
w x  .4 R. Ferrari, Am. J. Cardiol. 76 1995 17B–24B.
w x5 P.A. Baeuerle, D. Baltimore, in: P. Cohen, J.G. Foulkes
 .Eds. , Molecular aspects of cellular regulation, hormonal
control, regulation of gene transcription, Elsevier, Amster-
dam, 1991, pp. 409–432.
w x  .6 T.A. Lieberman, D. Baltimore, Mol. Cell. Biol. 10 1990
2327–2334.
w x  .7 P.B. Sehgal, Res. Immunol. 143 1992 724–734.
w x  .8 W. Fiers, FEBS Lett. 285 1991 199–212.
w x9 D.A. Brenner, M. O’Hara, P. Angel, M. Choikier, M. Karin,
 .Nature 337 1989 661–663.
w x10 H. Sato, Z.-Q. Zhao, S. McGee, M.W. Williams, J.W.
Hammon jr., J. Vinter-Johansen, J. Thorac. Cardiovasc.
 .Surg. 110 1995 302–314.
w x11 R.G. Woolfson, V.C. Patel, G.H. Neild, D.M. Yellon, Circu-
 .lation 91 1995 1545–1551.
w x12 J.C. Hartman, G.M. Kurc, T.G. Hullinger, T.M. Wall, R.M.
 .Sheehy, R.M. Shebucki, J. Pharmacol. Exp. Ther. 270 1994
1071–1076.
w x  .13 A.S. Weyrich, X. Ma, A.M. Lefer, Circulation 86 1992
279–288.
w x14 J.L. Zweier, P. Wang, P. Kuppusamy, J. Biol. Chem. 270
 .1995 304–307.
w x  .15 R. Schreck, P.A. Baeuerle, Methods Enzymol. 234 1994
151–163.
w x16 Q.-W. Xie, Y. Kashiwabara, C. Nathan, J. Biol. Chem. 269
 .1994 4705–4709.
w x  .17 K.A. Piez, M. Sporn Eds. , Transforming growth factor-bs.
Chemistry, biology and therapeutics. Ann. N.Y. Acad. Sci.
 .593 1990 1–379.
w x  .18 W.A. Border, E. Ruoslahti, J. Clin. Invest. 90 1992 1–7.
w x  .19 S.M. Wahl, J. Exp. Med. 180 1994 1587–1590.
w x20 D.J. Pinsky, B. Cai, X. Yang, C. Rodriguez, R.R. Sciacca,
 .P.J. Cannon, J. Clin. Invest. 95 1995 677–685.
w x  .21 C.L. Dent, D.S. Latchman, in: D.S. Latchman Ed. , Tran-
scription factors. A Practical Approach, IRL Press, New
York, pp. 1–26.
w x  .22 P. Chomczynski, N. Sacchi, Anal. Biochem. 162 1987
156–159.
w x  .23 B. Chandrasekar, G.L. Freeman, FEBS Lett. 401 1997
30–34.
w x24 B. Chandrasekar, P.C. Melby, D.A. Troyer, G.L. Freeman,
 .Biochem. Biophys. Res. Commun. 223 1996 365–371.
w x25 D.B. Masters, C.T. Griggs, C.B. Berde, Biotechniques 12
 .1992 902–911.
w x26 A.C. Nolan, W.A. Clark Jr., T. Karwoski, R. Zak, Proc.
 .Natl. Acad. Sci. USA 80 1983 6046–6050.
w x27 I.J. Benjamin, J.E. Jalil, L.B. Tan, K. Cho, K.T. Weber,
 .W.A. Clark, Circ. Res. 65 1989 657–670.
w x28 J. Kajstura, W. Cheng, K. Reiss, W.A. Clark, E.H. Sonnen-
blick, S. Krajewski, J.C. Reed, G. Olivetti, P. Anversa, Lab.
 .Invest. 74 1996 86–107.
w x29 H. Mansour, M. Levacher, M.A. Gougerot-Pocidalo, B.
 .Rouveix, J. Pocidalo, J. Pharmacol. Exp. Ther. 236 1986
476–480.
w x30 R. Schreck, B. Meier, D.N. Mannel, W. Droge, P.A.
 .Baeuerle, J. Exp. Med. 175 1992 1181–1194.
w x31 S. Mankhetkorn, Z. Abedinzadeh, C. Houee-Levin, Free
 .Radic. Biol. Med. 17 1994 517–527.
w x32 J. Liu, M.K. Shinegawa, L.J. Yan, A. Mori, B.N. Ames,
 .Free Radic. Res. 24 1996 461–472.
w x33 Gessner, P.K., Gessner, T. in: Disulfiram and its metabolite
diethyldithiocarbamate, Chapman and Hall, New York, 1992.
w x34 R. Bolli, B.S. Patel, M.O. Jeroudi, E.K. Lai, P.B. McCay, J.
 .Clin. Invest. 82 1988 476–485.
w x35 D.V. Kuprash, I.A. Udalova, R.L. Turetskaya, N.R. Rice,
 .S.A. Nedospasov, Oncogene 11 1995 97–106.
w x  .36 L.J. Old, Science 230 1985 630–632.
w x  .37 J. Le, J. Vilcek, Lab. Invest. 56 1987 234–248.
w x  .38 F.L. Abel, Am. J. Physiol. 257 1989 R1265–R1281.
w x39 A.F. Suffredini, R.E. Fromm, M.M. Parker, M. Brenner,
J.A. Kovacs, R.A. Wesley, J.E. Parrillo, N. Engl. J. Med.
 .321 1989 280–287.
w x  .40 D.R. Murray, G.L. Freeman, Circ. Res. 78 1996 154–160.
w x41 A. Zentella, K. Manogue, A. Cerami, Prog. Clin. Biol. Res.
 .367 1991 9–24.
w x42 M.S. Finkel, C.V. Oddis, T.D. Jacob, S.C. Watkins, B.G.
 .Hattler, R.L. Simmons, Science 257 1992 387–389.
w x43 A. Herskowitz, S. Choi, A.A. Ansari, S. Wesselingh, Am. J.
 .Pathol. 146 1995 419–428.
w x44 J.-C.L. Plumier, H.A. Robertson, R.W. Currie, J. Mol. Cell
 .Cardiol. 28 1996 1251–1260.
w x45 S. Akira, T. Hirano, T. Taga, T. Kishimoto, FASEB J. 4
 .1990 2860–2867.
w x  .46 D. Aderka, J. Le, J. Vilcek, J. Immunol. 143 1989 3517–
3523.
w x47 R. Schindler, J. Mancilla, S. Endres, R. Ghorbani, S. Clark,
 .C. Dinarello, Blood 75 1990 40–47.
w x48 H.E. Grenett, D.E. Danley, C.A. Strick, L.C. James, I.
Otterness, N. Fuentes, J.E. Nesbitt, G.M. Fuller, Gene 101
 .1991 267–271.
w x49 R.A. Kelley, J.-L. Balligand, T.W. Smith, Circ. Res. 79
 .1996 363–380.
w x50 C.E.P. Goldring, R. Narayanan, P. Lagadec, J.-F. Jeannin,
 .Biochem. Biophys. Res. Commun. 209 1995 73–79.
w x51 D.A. Geller, A.K. Nussler, M. Di Silvio, C.J. Lowenstein,
R.A. Shapiro, S.C. Wang, R.L. Simmons, T.R. Billiar, Proc.
 .Natl. Acad. Sci. USA 90 1993 522–526.
( )B. Chandrasekar et al.rBiochimica et Biophysica Acta 1406 1998 91–106106
w x52 D.C. Junquero, T. Scott-Burden, V.B. Schini, P.M. Van-
 .houtte, J. Physiol. 454 1992 451–465.
w x53 V.B. Schini, W. Durante, E. Elizondo, T. Scott-Burden,
D.C. Junquero, A.I. Schefer, P.M. Vanhoutte, Eur. J. Phar-
 .macol. 216 1992 379–383.
w x54 Y. Vodovotz, C. Bogdan, J. Paik, Q.-W. Xie, C. Nathan, J.
 .Exp. Med. 178 1993 605–613.
w x55 A.M. Lefer, X.L. Ma, A.S. Weyrich, R. Scalia, Proc. Natl.
 .Acad. Sci. USA 90 1993 1018–1022.
w x56 D.J. Loegering, C.A. Richard, C.B. Davison, G.A. Wirth,
 .Life Sci. 57 1995 169–176.
w x57 A. Mulsch, B. Schray-Utz, P.I. Mordvintcev, S. Hauschildt,
 .R. Busse, FEBS Lett. 321 1993 215–218.
